» Articles » PMID: 8345199

Transforming Growth Factor-beta Suppresses Activation and Proliferation of Microglia in Vitro

Overview
Journal J Immunol
Date 1993 Aug 15
PMID 8345199
Citations 81
Authors
Affiliations
Soon will be listed here.
Abstract

Transforming growth factor-beta (TGF-beta) has been shown to be produced in the central nervous system (CNS). The functions of TGF-beta, however, remain to be elucidated. We investigated the effects of TGF-beta on the proliferation, activation, and cytokine production of isolated microglia in vitro. TGF-beta dose-dependently suppressed the acid phosphatase activity of and formation of superoxide anion by LPS activated microglia. It also suppressed the IFN-gamma-induced expression of class II MHC Ag- and the production of cytokines, IL-1, IL-6, and TNF-alpha, by these cells. TGF-beta also inhibited the proliferation of microglia that was induced by either GM-CSF or M-CSF. Because various immunoregulatory cytokines are produced in the CNS that serve as autocrine or paracrine mediators it is suggested that TGF-beta could be a negative regulator in the CNS cytokine network. It may play a role in the development of various disease processes in the CNS by inhibiting the function of microglia in inflammation or in immunoregulation.

Citing Articles

The two-sided battlefield of tumour-associated macrophages in glioblastoma: unravelling their therapeutic potential.

Xiong J, Zhou X, Su L, Jiang L, Ming Z, Pang C Discov Oncol. 2024; 15(1):590.

PMID: 39453528 PMC: 11511804. DOI: 10.1007/s12672-024-01464-5.


Glioblastoma and Immune Checkpoint Inhibitors: A Glance at Available Treatment Options and Future Directions.

Rodriguez S, Tataranu L, Kamel A, Turliuc S, Rizea R, Dricu A Int J Mol Sci. 2024; 25(19).

PMID: 39409094 PMC: 11477435. DOI: 10.3390/ijms251910765.


Immunotherapeutic Strategies for the Treatment of Glioblastoma: Current Challenges and Future Perspectives.

Salvato I, Marchini A Cancers (Basel). 2024; 16(7).

PMID: 38610954 PMC: 11010873. DOI: 10.3390/cancers16071276.


Circulating microRNAs as diagnostic biomarkers for ischemic stroke: evidence from comprehensive analysis and real-world validation.

Wang Y, Su X, Leung G, Ren B, Zhang Q, Xiong Z Int J Med Sci. 2023; 20(8):1009-1023.

PMID: 37484808 PMC: 10357437. DOI: 10.7150/ijms.83963.


Vγ1 and Vγ4 gamma-delta T cells play opposing roles in the immunopathology of traumatic brain injury in males.

Abou-El-Hassan H, Rezende R, Izzy S, Gabriely G, Yahya T, Tatematsu B Nat Commun. 2023; 14(1):4286.

PMID: 37463881 PMC: 10354011. DOI: 10.1038/s41467-023-39857-9.